Literature DB >> 31559593

New Targets of Kunitz-Type Peptide from Sea Anemone Heteractis magnifica.

A N Kvetkina1, L A Kaluzhskiy2, E V Leychenko3,4, M P Isaeva3, A S Ivanov2, E P Kozlovskaya3.   

Abstract

The interaction of Kunitz-type peptide, HMIQ3c1, from the sea anemone Heteractis magnifica with several serine proteases, including inflammatory proteases, was investigated using the surface plasmon resonance approach. We showed that the recombinant analog of HMIQ3c1 forms sufficiently strong complexes with trypsin (KD = 1.07 × 10-9 М) and chymotrypsin (KD = 4.70 × 10-8 М). Analysis of thermodynamic parameters of HMIQ3c1/chymotrypsin revealed significant contribution of the entropic factor to the complex formation. The formation of specific complexes of HMIQ3c1 with the kallikrein (KD = 2.81 × 10-8 М) and neutrophil elastase (KD = 1.11 × 10-7 М) indicates its anti-inflammatory activity and makes prospects to use the peptide as a potential therapeutic agent.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31559593     DOI: 10.1134/S1607672919040033

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  2 in total

1.  Kunitz-Type Peptides from Sea Anemones Protect Neuronal Cells against Parkinson's Disease Inductors via Inhibition of ROS Production and ATP-Induced P2X7 Receptor Activation.

Authors:  Aleksandra Kvetkina; Evgeny Pislyagin; Ekaterina Menchinskaya; Ekaterina Yurchenko; Rimma Kalina; Sergei Kozlovskiy; Leonid Kaluzhskiy; Alexander Menshov; Natalia Kim; Steve Peigneur; Jan Tytgat; Alexis Ivanov; Naira Ayvazyan; Elena Leychenko; Dmitry Aminin
Journal:  Int J Mol Sci       Date:  2022-05-04       Impact factor: 6.208

2.  Sea Anemone Kunitz-Type Peptides Demonstrate Neuroprotective Activity in the 6-Hydroxydopamine Induced Neurotoxicity Model.

Authors:  Oksana Sintsova; Irina Gladkikh; Margarita Monastyrnaya; Valentin Tabakmakher; Ekaterina Yurchenko; Ekaterina Menchinskaya; Evgeny Pislyagin; Yaroslav Andreev; Sergey Kozlov; Steve Peigneur; Jan Tytgat; Dmitry Aminin; Emma Kozlovskaya; Elena Leychenko
Journal:  Biomedicines       Date:  2021-03-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.